Paloma Millan-Billi

Prof. Paloma Millan-Billi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RORubén Osuna-Gómez
Rubén Osuna-Gómez
MMMaria Mulet
Maria Mulet
SBSilvia Barril
Silvia Barril
ECElisabet Canto
Elisabet Canto
PMPaloma Millan-Billi
Paloma Millan-Billi
silvia vidalsilvia vidal
silvia vidal
Interstitial lung diseases (ILDs) are characterized by inflammation or fibrosis of the pulmonary parenchyma. Despite the involvement of immune cells and soluble mediators in pulmonary fibrosis, the influence of antimicrobial peptides (AMPs) remains underexplored. These effector molecules display a range of activities, which include immunomodulation and wound repair. Here, we investigate the role of AMPs in the development of fibrosis in ILD. We compare the concentration of different AMPs and different cytokines in 46 fibrotic (F-ILD) and 17 non-fibrotic (NF-ILD) patients by ELISA and using peripheral blood mononuclear cells from in vitro stimulation in the presence of lysozyme or secretory leukocyte protease inhibitor (SLPI) from 10 healthy donors. We observed that bronchoalveolar lavage (BAL) levels of AMPs were decreased in F-ILD patients (lysozyme: p < 0.001; SLPI: p < 0.001; LL-37: p < 0.001; lactoferrin: p = 0.47) and were negatively correlated with levels of TGF-β (lysozyme: p = 0.02; SLPI: p < 0.001) and IL-17 (lysozyme: p < 0.001; SLPI: p < 0.001). We observed that lysozyme increased the percentage of CD86+ macrophages (p < 0.001) and the production of TNF-α (p < 0.001). We showed that lysozyme and SLPI were associated with clinical parameters (lysozyme: p < 0.001; SLPI: p < 0.001) and disease progression (lysozyme: p < 0.001; SLPI: p = 0.01). These results suggest that AMPs may play an important role in the anti-fibrotic response, regulating the effect of pro-fibrotic cytokines. In addition, levels of lysozyme in BAL may be a potential biomarker to predict the progression in F-ILD patients.

6 April 2021 in Journal of Bronchology & Interventional Pulmonology
Verified
Journal Article
Closed access
CSCandela Serra
Candela Serra
ATAlfons Torrego
Alfons Torrego
VPVirginia Pajares
Virginia Pajares
PMPaloma Millan-Billi
Paloma Millan-Billi
SBSilvia Barril
Silvia Barril
DCDiego Castillo
Diego Castillo
Background: Bronchoalveolar lavage (BAL) is a technique classically used for the study of diffuse interstitial lung diseases (DILDs). Given the recent advances in the diagnosis of DILD by transbronchial cryobiopsy (TBCB), it is relevant to assess what BAL can contribute to TBCB. Patients and Methods: This is a retrospective descriptive study that included patients with DILD who, between 2013 and 2017, underwent BAL and TBCB in the same bronchoscopy intervention. We evaluated the complementary information provided by BAL to TBCB that facilitated the diagnosis by a multidisciplinary committee. Epidemiological, clinical, and functional variables and high-resolution chest tomography findings were recorded, along with complications associated with the procedures. Results: A total of 60 patients were included. TBCB, conditioned by the underlying radiologic pattern, provided diagnostic information in 75% of cases. BAL provided complementary information that supported the diagnosis and treatment in 22% of cases. Differential BAL findings were related to microbiology, cell count, and immunology. Regarding the safety of the procedure, 47% of the patients experienced complications, although none were serious. Conclusion: BAL findings contribute to TBCB findings in the diagnosis of DILDs, with no serious complications associated with their combined use.

1 October 2021 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
PMPaloma Millan-Billi
Paloma Millan-Billi
VRVirginia Pajares Ruiz
Virginia Pajares Ruiz
RVRubén Guerrero Vara
Rubén Guerrero Vara
JAJordi Villalba Auñón
Jordi Villalba Auñón
AFAlfons Torrego Fernandez
Alfons Torrego Fernandez

1 October 2021 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
PMPaloma Millan-Billi
Paloma Millan-Billi
VRVirginia Pajares Ruiz
Virginia Pajares Ruiz
RVRubén Guerrero Vara
Rubén Guerrero Vara
JAJordi Villalba Auñón
Jordi Villalba Auñón
AFAlfons Torrego Fernandez
Alfons Torrego Fernandez